NCT04004871 2025-12-11
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma
Guangxi Medical University
Phase 2 Completed
Clinical Trials
89 trialsNCT03358472 2025-12-03
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
Incyte Corporation
Phase 3 Completed
NCT04356170 2025-09-02
TPFmORL
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed
NCT05007106 2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00665392 2025-08-01
ECHO-07
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Completed
NCT02358031 2025-07-18
MK-3475-048
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03944915 2025-05-11
DEPEND
University of Chicago
Phase 2 Completed
NCT03107182 2025-05-06
OPTIMA-II
University of Chicago
Phase 2 Completed
NCT00544414 2025-02-19
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
City of Hope Medical Center
Phase 2 Completed
NCT04649476 2025-01-10
NEOPBOSCC
Hospital of Stomatology, Wuhan University
Phase 2 Completed
NCT00868491 2024-10-18
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Institute of Oncology Ljubljana
Phase 2 Completed
NCT02258659 2024-09-24
OPTIMA
University of Chicago
Phase 2 Completed
NCT01847326 2024-07-31
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
University of Chicago
Phase 1 Completed
NCT02778191 2024-05-06
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
University Medical Center Groningen
Completed
NCT00502463 2024-02-07
ASOG-HNO1
Austrian South Oncology Group
Phase NA Completed
NCT01693718 2024-01-29
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
University of Chicago
Phase 2 Completed
NCT01914900 2023-10-19
Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Completed
NCT06062602 2023-10-06
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC
Presage Biosciences
Phase EARLY_PHASE1 Completed
NCT02741570 2023-09-21
CheckMate 651
Bristol-Myers Squibb
Phase 3 Completed
NCT02484677 2023-05-26
5-FU
Assistance Publique Hopitaux De Marseille
Phase 4 Completed
NCT02940925 2023-04-12
TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Completed
NCT00274937 2022-10-25
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Children's Oncology Group
Phase 3 Completed
NCT02268695 2022-08-23
TPExtreme
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed
NCT01864772 2022-08-19
ELANFIT
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed
NCT01884259 2022-05-26
HNO-2
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 2 Completed
NCT04834206 2022-05-10
Nedaplatin in Treatment for Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Completed
NCT02052960 2021-11-02
RESGEX
Glycotope GmbH
Phase 2 Completed
NCT00592501 2021-10-26
Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma
Massachusetts General Hospital
Phase 2 Completed
NCT01528618 2021-10-04
Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Completed
NCT00003627 2021-02-21
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
UNICANCER
Phase 3 Completed
NCT00006051 2021-02-21
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
UNICANCER
Phase 2 Completed
NCT00736944 2020-09-09
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
Washington University School of Medicine
Phase 2 Completed
NCT02658214 2020-08-20
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
AstraZeneca
Phase 1 Completed
NCT00721513 2020-04-07
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT03389295 2019-12-16
Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Fudan University
Phase 2 Completed
NCT01836029 2019-10-29
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Celgene
Phase 2 Completed
NCT00468169 2019-10-09
EPIC
University of Chicago
Phase 2 Completed
NCT01063075 2019-09-26
A Study in Advanced Solid Tumors
Eli Lilly and Company
Phase 2 Completed
NCT00379262 2019-08-07
Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
Hong Kong Nasopharyngeal Cancer Study Group Limited
Phase 3 Completed
NCT01233843 2019-01-18
2007/02
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3 Completed
NCT00756444 2018-11-15
A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
Amgen
Phase 2 Completed
NCT00002839 2018-07-09
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00003888 2018-07-09
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00498953 2018-07-09
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1/2 Completed
NCT00462735 2018-03-13
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00995293 2018-03-02
Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial
Sanofi
Phase 3 Completed
NCT00408694 2018-01-30
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00052429 2018-01-09
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT01326559 2017-08-16
Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
Hong Kong Nasopharyngeal Cancer Study Group Limited
Phase 2 Completed
NCT01911598 2017-07-06
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Genentech, Inc.
Phase 1 Completed